The hardware and bandwidth for this mirror is donated by dogado GmbH, the Webhosting and Full Service-Cloud Provider. Check out our Wordpress Tutorial.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]dogado.de.
Mapper-based survival analysis with transcriptomics data is designed to carry out. Mapper-based survival analysis is a modification of Progression Analysis of Disease (PAD) where survival data is taken into account in the filtering function. More details in: J. Fores-Martos, B. Suay-Garcia, R. Bosch-Romeu, M.C. Sanfeliu-Alonso, A. Falco, J. Climent, "Progression Analysis of Disease with Survival (PAD-S) by SurvMap identifies different prognostic subgroups of breast cancer in a large combined set of transcriptomics and methylation studies" <doi:10.1101/2022.09.08.507080>.
Version: | 1.0.0 |
Depends: | R (≥ 3.5.0) |
Imports: | base, cluster, stats, survival, utils, visNetwork, ComplexHeatmap, circlize, devtools |
Suggests: | rmarkdown, knitr, testthat (≥ 3.0.0) |
Published: | 2024-06-01 |
DOI: | 10.32614/CRAN.package.GSSTDA |
Author: | Miriam Esteve [aut, cre], Raquel Bosch [aut], Jaume Forés [aut], Joan Climent [aut], Antonio Falco [aut] |
Maintainer: | Miriam Esteve <miriam.estevecampello at uchceu.es> |
License: | GPL-3 |
NeedsCompilation: | no |
Materials: | README |
CRAN checks: | GSSTDA results |
Reference manual: | GSSTDA.pdf |
Vignettes: |
GSSTDA-vignette |
Package source: | GSSTDA_1.0.0.tar.gz |
Windows binaries: | r-devel: GSSTDA_1.0.0.zip, r-release: GSSTDA_1.0.0.zip, r-oldrel: GSSTDA_1.0.0.zip |
macOS binaries: | r-release (arm64): GSSTDA_1.0.0.tgz, r-oldrel (arm64): GSSTDA_1.0.0.tgz, r-release (x86_64): GSSTDA_1.0.0.tgz, r-oldrel (x86_64): GSSTDA_1.0.0.tgz |
Old sources: | GSSTDA archive |
Please use the canonical form https://CRAN.R-project.org/package=GSSTDA to link to this page.
These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.
Health stats visible at Monitor.